Genmab AS (GMAB) — Working Capital to Net Assets Ratio
Genmab AS (GMAB) has a Working Capital to Net Assets ratio of 24.9% as of December 2025. Working capital of $1.45 Billion (current assets of $2.88 Billion minus current liabilities of $1.42 Billion) is measured against net assets of $5.83 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See GMAB net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Genmab AS Working Capital to Net Assets (2002–2025)
This chart shows how Genmab AS's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 24.9%, reflecting working capital of $1.45 Billion against net assets of $5.83 Billion USD. Check Genmab AS (GMAB) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Genmab AS (2002–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Genmab AS from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Genmab AS market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 24.9% | $1.45 Billion | $5.83 Billion | $2.88 Billion | $1.42 Billion | ▼ -36.5 pp |
| 2024 | 61.4% | $22.55 Billion | $36.70 Billion | $27.85 Billion | $5.31 Billion | ▼ -35.5 pp |
| 2023 | 97.0% | $30.66 Billion | $31.61 Billion | $33.14 Billion | $2.48 Billion | ▲ +0.2 pp |
| 2022 | 96.7% | $26.39 Billion | $27.28 Billion | $28.22 Billion | $1.82 Billion | ▲ +1.4 pp |
| 2021 | 95.4% | $21.17 Billion | $22.20 Billion | $22.74 Billion | $1.57 Billion | ▲ +3.6 pp |
| 2020 | 91.7% | $17.54 Billion | $19.12 Billion | $18.79 Billion | $1.25 Billion | ▼ -1.0 pp |
| 2019 | 92.7% | $13.02 Billion | $14.05 Billion | $13.96 Billion | $938.00 Million | ▲ +5.5 pp |
| 2018 | 87.2% | $6.99 Billion | $8.01 Billion | $7.43 Billion | $443.35 Million | ▼ -4.2 pp |
| 2017 | 91.4% | $5.73 Billion | $6.27 Billion | $6.06 Billion | $327.12 Million | ▼ -1.6 pp |
| 2016 | 92.9% | $4.49 Billion | $4.83 Billion | $4.90 Billion | $411.54 Million | ▼ -0.4 pp |
| 2015 | 93.3% | $3.25 Billion | $3.49 Billion | $3.67 Billion | $414.39 Million | ▼ -10.5 pp |
| 2014 | 103.8% | $2.11 Billion | $2.03 Billion | $2.77 Billion | $655.97 Million | ▼ -15.3 pp |
| 2013 | 119.1% | $785.48 Million | $659.52 Million | $1.69 Billion | $907.50 Million | ▼ -3.6 pp |
| 2012 | 122.7% | $470.16 Million | $383.19 Million | $1.65 Billion | $1.18 Billion | ▲ +11.7 pp |
| 2011 | 111.0% | $540.07 Million | $486.42 Million | $1.52 Billion | $976.73 Million | ▲ +9.7 pp |
| 2010 | 101.4% | $1.09 Billion | $1.08 Billion | $2.42 Billion | $1.32 Billion | ▲ +4.1 pp |
| 2009 | 97.3% | $1.26 Billion | $1.30 Billion | $2.16 Billion | $894.34 Million | ▲ +55.9 pp |
| 2008 | 41.4% | $905.34 Million | $2.19 Billion | $1.97 Billion | $1.06 Billion | ▼ -57.5 pp |
| 2007 | 98.9% | $2.85 Billion | $2.88 Billion | $3.92 Billion | $1.07 Billion | ▲ +0.3 pp |
| 2006 | 98.6% | $1.59 Billion | $1.61 Billion | $1.77 Billion | $185.80 Million | ▲ +1.5 pp |
| 2005 | 97.1% | $1.09 Billion | $1.12 Billion | $1.32 Billion | $237.18 Million | ▲ +2.0 pp |
| 2004 | 95.0% | $1.12 Billion | $1.18 Billion | $1.19 Billion | $69.96 Million | ▲ +3.7 pp |
| 2003 | 91.3% | $992.34 Million | $1.09 Billion | $1.07 Billion | $75.11 Million | ▲ +1.4 pp |
| 2002 | 89.9% | $1.26 Billion | $1.40 Billion | $1.42 Billion | $160.40 Million | — |